Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first?

Current Alzheimer Research

Volumn 5, Issue 5, 2008, Pages 457-468

  Mancuso, Michelangelo ^a   Orsucci, Daniele ^a   Siciliano, Gabiele ^a   Murri, Luigi ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Alzheimer's disease; Haplogroups; Mitochondria; mtDNA; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN; MITOCHONDRIAL DNA; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN; CELL DEATH; CYBRID; CYTOCHROME C OXIDASE DEFICIENCY; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; FIBROBLAST; GENE MUTATION; HUMAN; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOLECULAR MODEL; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; THROMBOCYTE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; MUTATION;

EID: 53549097920     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720508785908946     Document Type: Review

References (108)

1. DiMauro S and Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 348:2656-2668 (2003).
2. Noji H and Yoshida M. The rotary machine of the cell, ATP synthase. J Biol Chem 276:1665-1668 (2001).
3. Filosto M and Mancuso M. Mitochondrial diseases: a nosological update. Acta Neurol Scand 115:211-221 (2007).
4. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766 (2001).
5. Davis DG, Schmitt FA, Wekstein DR and Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropath Exp Neurol 58:376-388 (1999).
6. Hardy J and Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356 (2002).
7. Mancuso M, Coppede F, Migliore L, Siciliano G and Murri L. Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimers Dis 10:59-73 (2006).
8. Petrozzi L, Ricci G, Giglioli NJ, Siciliano G and Mancuso M. Mitochondria and neurodegeneration. Biosci Rep 27:87-104 (2007).
9. Krantic S, Mechawar N, Reix S and Quirion R. Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci 28:670-676 (2005).
10. Mattson MP, Parting J and Begley JG. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res 807:76-82(1998).
11. Ricci JE, Munoz-Pinedo C, Fitzgerald P, Bailly-Maitre B, Perkins GA, Yadava N, et al. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117:773-786 (2004).
12. Genova ML, Pich MM, Bernacchia A, Bianchi C, Biondi A, Bovina C, et al. The mitochondrial production of reactive oxygen species in relation to aging and pathology. Ann N Y Acad Sci 1011:86-100(2004).
13. Wong-Riley M, Antuono P, Ho KC, Egan R, Hevner R, Liebl W, et al. Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Vision Res 37:3593-3608 (1997).
14. Weissman L, de Souza-Pinto NC, Stevnsner T and Bohr VA. DNA repair, mitochondria, and neurodegeneration. Neuroscience 145:1318-1329(2007).
15. Mancuso M, Coppedè F, Murri L and Siciliano G. Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? Antioxid Redox Signal 9:1631-1646 (2007).
16. Wang H, Yu SW, Koh DW, Lew J, Coombs C, Bowers W, et al. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J Neurosci 24:10963-10973 (2004).
17. 2+-dependent generation of mitochondrial reactive oxygen species serves as a signal for poly(ADP-ribose) polymerase-1 activation during glutamate excitotoxicity. J Physiol 585:741-558 (2007).
18. Jou MJ, Jou SB, Guo MJ, Wu HY and Peng TL Mitochondrial reactive oxygen species generation and calcium increase induced by visible light in astrocytes. Ann N Y Acad Sci 1011:45-56 (2004).
19. Alano CC, Kauppinen TM, Valls AV and Swanson RA. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci U S A 103:9685-9690 (2006).
20. Muller-Hocker J. Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: an agerelated alteration. J Neurol Sci 100:14-21 (1990).
21. Trifunovic A. Mitochondrial DNA and ageing. Biochim Biophys Acta 1757:611-617(2006).
22. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink IN, Rovio AT, Bruder CE, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429:417-423 (2004).
23. Vermulst M, Wanagat J, Kujoth GC, Bielas JH, Rabinovitch PS, Prolla TA, et al. DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat Genet 40:392-394 (2008).
24. Guix FX, Uribesalgo I, Coma M and Munoz FJ. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 76:126-152 (2005).
25. Mecocci P, MacGarvey U and Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36:747-751 (1994).
26. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19:1959-1964 (1999).
27. Nunomura A, Chiba S, Lippa CF, Cras P, Kalaria RN, TakedaA, et al. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol Dis 17:108-113 (2004).
28. Wang J, Xiong S, Xie C, Markesbery WR and Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 93:953-962 (2005).
29. Butterfield DA. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res 1000:1-7 (2004).
30. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64:1152-1156 (2005).
31. Wang J, Markesbery WR and Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem 96:825-32 (2006).
32. Migliore L, Fontana I, Trippi F, Colognato R, Coppedè F, Tognoni G, et al. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging 26:567-573 (2005).
33. Ding Q, Dimayuga E and Keller JN. Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease. Curr Alzheimer Res 4:73-79 (2007).
34. Altieri F, Grillo C, Maceroni M and Chichiarelli S. DNA damage and repair: from molecular mechanisms to health implications. Antioxid Redox Signal 10:891-937 (2008).
35. Lakshmipathy U and Campbell C. Antisense-mediated decrease in DNA ligase HI expression results in reduced mitochondrial DNA integrity. Nucleic Acids Res 29:668-676 (2001).
36. Lovell MA, Gabbita SP and Markesbery WR. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J Neurochem 72:771-776 (1999).
37. Lovell MA, Xie C and Markesbery WR. Decreased base excision repair and increased helicase activity in Alzheimer's disease brain. Brain Res 855:116-123 (2000).
38. Jacobsen E, Beach T, Shen Y, Li R and Chang Y. Deficiency of the Mrel lDNA repair complex in Alzheimer's disease brains. Brain Res Mol 128:1-7(2004).
39. Davydov V, Hansen LA and Shackelford DA. Is DNA repair compromised in Alzheimer's disease? Neurobiol Aging 24:953-968 (2003).
40. Fishel ML, Vasko MR and Kelley MR. DNA repair in neurons: so if they don't divide what's to repair? Mutat Res 614:24-36 (2007).
41. rd and Bohr VA. The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair (Amst) 6:544-659 (2007).
42. Dogru-Abbasoglu S, Inceoglu M, Parildar-Karpuzoglu H, Hanagasi HA, Karadag B, Gurvit H, et al. Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer's disease. Neurosci Lett 404:258-261 (2006).
43. Coppedè F, Mancuso M, Lo Gerfo A, Manca ML, Petrozzi L, Migliore L, et al. A Ser326Cys polymorphism in the DNA repair gene hOGGl is not associated with sporadic Alzheimer's disease. Neurosci Lett 414:282-285 (2007).
44. Dogru-Abbasoglu S, Aykac-Toker G, Hanagasi HA, Gurvit H, Emre M and Uysal M. The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer's disease. Neurol Sci 28:31-34 (2007).
45. Coppedè F, Mancuso M, Siciliano G, Migliore L and Murri L. Genes and the environment in neurodegeneration. Biosci Rep 26:341-367(2006).
46. Cherny RA, Legg JT, McLean CA, Fairlie DP, Huang X, Atwood CS, et al. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. J Biol Chem 274:23223-23228 (1999).
47. Khan A, Dobson JP and Exley C. Redox cycling of iron by Abeta(42). Free Radic Biol Med 40:557-569 (2006).
48. Honda K, Smith MA, Zhu X, Baus D, Merrick WC, Tartakoff AM, et al. Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J Biol Chem:280:20978-20986 (2005).
49. Azari NP, Pettigrew KD, Schapiro MB, Haxby JV, Grady CL, Pietrini P, et al. Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data. J Cereb Blood Flow Metab 13:438-447 (1993).
50. Blass JP, Sheu RK and Gibson GE. Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann NY Acad Sci 903:204-221 (2000).
51. Wallace DC. Mitochondrial diseases in man and mouse. Science 283:1482-1488 (1999).
52. Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, et al. Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol 48:297-303 (2000).
53. Bubber P, Haroutunian V, Fisch G, Blass JP and Gibson GE. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 57:695-703 (2005).
54. Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A, et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci U S A 105:4441-4446 (2008).
55. Baloyannis SJ. Mitochondrial alterations in Alzheimer's disease. J Alzheimers Dis 9:119-126 (2006).
56. Stewart P, Hayakawa K, Akers M and Vinters H. A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest 67:734-742 (1992)
57. Trimmer PA and Borland MK. Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement. Antioxid Redox Signal 7:1101-1109 (2005).
58. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, et al. Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol 66:525-532 (2007).
59. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, et al. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 3:614-615 (2007).
60. Hauptmann S, Scherping I, Dröse S, Brandt U, Schulz KL, Jendrach M, et al. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging, in press, doi:10.1016/j.neurobiolaging. 2007. 12.005 (2008).
61. Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, et al. Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res 70:357-360 (2002).
62. Mutisya EM, Bowling AC and Beal MF. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 63:2179-2184(1994).
63. Simonian SA and Hyman BT. Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J Neuropathol Exp Neurol 53:508-512 (1994).
64. Maurer I, Zierz S and Moller HJ. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 21:455-462 (2000).
65. Bosetti F, Brizzi F, Barogi S, Mancuso M, Siciliano G, Tendi EA, et al. Cytochrome c oxidase and mitochondrial F1FO-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging 23:371-376 (2002).
66. Parker W Jr, Filley CM and Parks JK. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40:1302-1303 (1990).
67. Cardoso SM, Proenca MT, Santos S, Santana I and Oliveira CR. Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging 25:105-110 (2004).
68. Valla J, Schneider L, Niedzielko T, Coon KD, Caselli R, Sabbagh MN, et al. Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion 6:323-330 (2006).
69. Mancuso M, Filosto M, Bosetti F, Ceravolo R, Rocchi A, Tognoni G, et al. Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Exp Neurol 182:421-426 (2003).
70. Fukui H, Diaz F, Garcia S and Moraes CT. Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 104:14163-14168 (2007).
71. Fukui H and Moraes CT. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci 31(5):1682-9 (2008).
72. King MP and Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246:500-503 (1989).
73. Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett JP Jr, et al. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 49:918-925 (1997).
74. Khan SM, Cassarino DS, Abramova NN, Keeney PM, Borland MK, Trimmer PA, et al. Alzheimer's disease cybrids replicate betaamyloid abnormalities through cell death pathways. Ann Neurol 48:148-155 (2000).
75. Cardoso SM, Santana I, Swerdlow RH and Oliveira CR. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J Neurochem 89:1417-1426 (2004).
76. Onyango IG, Bennett JP Jr and Tuttle JB. Endogenous oxidative stress in sporadic Alzheimer's disease neuronal cybrids reduces viability by increasing apoptosis through pro-death signaling pathways and is mimicked by oxidant exposure of control cybrids. Neurobiol Dis 19:312-322 (2005).
77. Onyango IG, Tuttle JB and Bennett JP Jr. Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE). Mol Cell Neurosci 29:333-343 (2005).
78. Trimmer PA, Keeney PM, Borland MK, Simon FA, Almeida J, Swerdlow RH, et al. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiol Dis 15:29-39 (2004).
79. Thiffault C and Bennett JP Jr. Cyclical mitochondrial deltapsiM fluctuations linked to electron transport, F0F1 ATP-synthase and mitochondrial Na+/Ca+2 exchange are reduced in Alzheimer's disease cybrids. Mitochondrion 5:109-119 (2005).
80. Ito S, Ohta S, Nishimaki K, Kagawa Y, Soma R, Kuno SY, et al. Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease. Proc Natl Acad Sci U S A 96:2099-2103 (1999).
81. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, McKee AC, Beal MF, et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23:471-476 (1994).
82. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17:171-184 (1993).
83. Coskun PE, Beal MF and Wallace DC. Alzheimer's brains harbor somatic mtDNAcontrol-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci U S A 101:10726-10731 (2004).
84. Chinnery PF, Taylor R, Howell N, Brown DT, Parsons TJ and Turnbull DM. Point mutations of the mtDNA control region in normal and neurodegenerative human brains. Am J Hum Genet 68:529-532 (2001).
85. Elson JL, Hermstadt C, Preston G, Thal L, Morris CM, Edwardson JA, et al. Does the mitochondrial genome play a role in the etiology of Alzheimer's disease? Hum Genet 119:241-254 (2006).
86. Torroni A, Huoponen K, Francalacci P, Petrozzi M, Morelli L, Scozzari R, et al. Classification of European mtDNAs from an analysis of three European populations. Genetics 144:1835-1850 (1996).
87. Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, Barone P, et al. Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet 13:748-752 (2005).
88. Chagnon P, Gee M, Filion M, Robitaille Y, Belouchi M and Gauvreau D. Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am J Med Genet 85:20-30 (1999).
89. Carrieri G, Bonafè M, De Luca M, Rose G, Varcasia O, Bruni A, et al. Mitochondrial DNA haplogroups and ApoE4 allele are nonindependent variables in sporadic Alzheimer's disease. Hum Genet 108:194-198 (2001).
90. van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, et al. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365:28-32 (2004).
91. Maruszak A, Canter JA, Styczyńska M, Zekanowski C and Barcikowska M. Mitochondrial haplogroup H and Alzheimer's disease-Is there a connection? Neurobiol Aging, in press, doi:10.1016/j.neurobiolaging.2008.01.004(2008).
92. Chinnery PF, Taylor GA, Howell N, Andrews RM, Morris CM, Taylor RW, et al. Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology 55:302-304 (2000).
93. Mancuso M, Nardini M, Micheli D, Rocchi A, Nesti C, Giglioli NJ, et al. Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany. Neurol Sci 28:142-147 (2007).
94. Samuels DC, Carothers AD, Horton R and Chinnery PF. The power to detect disease associations with mitochondrial DNA haplogroups. Am J Hum Genet 78:713-720 (2006).
95. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409-421 (2003).
96. Anandatheerthavarada HK, Biswas G, Robin MA and Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161:41-54 (2003).
97. Devi L, Prabhu BM, Galati DF, Avadhani NG and Anandatheerthavarada HK. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 26:9057-9068 (2006).
98. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304:448-452 (2004).
99. Hansson CA, Frykman S, Farmery MR, Tjernberg LO, Nilsberth C, Pursglove SE, et al. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J Biol Chem 279:51654-51660(2004).
100. Leissring MA, Farris W, Wu X, Christodoulou DC, Haigis MC, Guarente L, et al. Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria. Biochem J 383:439-446 (2004).
101. Falkevall A, Alikhani N, Bhushan S, Pavlov PF, Busch K, Johnson KA, et al. Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, Pre P. J Biol Chem 281:29096-29104 (2006).
102. Atamna H. Heme binding to amyloid-b peptide: mechanistic role in Alzheimer's disease. J Alzheimers Dis 10:255-266 (2006).
103. Atamna H and Frey WH II. A role for heme in Alzheimer's disease: heme binds amyloid b and has altered metabolism. Proc Natl Acad Sci US A 101:11153-11158(2004).
104. Ohyagi Y, Yamada T, Nishioka K, Clarke NJ, Tomlinson AJ, Naylor S, et al. Selective increase in cellular A beta 42 is related to apoptosis but not necrosis. Neuroreport 11:167-171 (2000).
105. Gabuzda D, Busciglio J, Chen LB, Matsudaira P and Yankner BA. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 269:13623-13628 (1994).
106. Drake J, Link CD and Butterfield DA. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid betapeptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol Aging 24:415-420 (2003).
107. Wang X, Su B, Perry G, Smith MA and Zhu X. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. Free Radic Biol Med 43:1569-1573 (2007).
108. Chen JX and Yan SD. Amyloid-beta-induced mitochondrial dysfunction. J Alzheimers Dis 12:177-184 (2007).